Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yuu Osanai is active.

Publication


Featured researches published by Yuu Osanai.


Bioorganic & Medicinal Chemistry | 2008

Inhibitory effect of the alkyl side chain of caffeic acid analogues on lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophages

Koji Uwai; Yuu Osanai; Takuma Imaizumi; Syu-ichi Kanno; Mitsuhiro Takeshita; Masaaki Ishikawa

Caffeic acid esters, one of the components of propolis, are known to show a variety of biological effects such as anti-tumor, anti-oxidant, and anti-inflammatory activities. Although, the anti-inflammatory activities of caffeic acid esters have been studied by analyzing their structure, the detailed mechanisms of their activities remain unclear. Thus, in this study, we examined the function of the ester functional group and the alkyl side chain (alcoholic part) and transformed caffeic acid to several derivatives. The inhibitory effect of these derivatives on NO production in murine macrophage RAW264.7 cells was dependent on the length and size of the alkyl moiety, and undecyl caffeate was the most potent inhibitor of NO production. In addition, individual experiments using undecanol, caffeic acid, undecanol plus caffeic acid, and undecyl caffeate showed that the connection between caffeic acid and the alkyl chain is critical for activity. Amide and ketone derivatives showed that not only the ester functional group but also the amide and ketone functional groups exhibit an inhibitory effect on NO production.


Oncology Reports | 2013

Induction of apoptosis by a potent caffeic acid derivative, caffeic acid undecyl ester, is mediated by mitochondrial damage in NALM-6 human B cell leukemia cells

Ayako Tomizawa; Syu-ichi Kanno; Yuu Osanai; Akane Goto; Chizuru Sato; Shin Yomogida; Masaaki Ishikawa

Caffeic acid esters have various biological activities, and we previously reported that undecyl caffeate (caffeic acid undecyl ester, CAUE), a new caffeic acid derivative, has strong pharmacological activity. The present study investigated the cytotoxicity of both CAUE and its parent compound, caffeic acid phenethyl ester (CAPE), and characterized the mechanisms by which they induce apoptosis in the human B cell leukemia cell line NALM-6. Treatment with CAUE reduced cell survival in NALM-6 cells but had no significant effect on the survival of normal lymphocytes. When assessing the 50% inhibitory concentration (IC50) for cytotoxicity, CAUE had 10-fold higher activity than CAPE in NALM-6 cells. CAUE treatment resulted in induction of apoptotic features in NALM-6 cells, including cleaved poly (ADP-ribose) polymerase and activated caspase-3. A caspase inhibitor completely blocked CAUE-induced apoptosis. CAUE treatment resulted in a concentration- and time-dependent decrease in both mitochondrial membrane potential and downregulation of Bcl-2 expression. Moreover, CAUE-induced apoptosis was enhanced in the Bcl-2 knockdown condition induced by small interfering RNA. These data suggest that CAUE-induced apoptosis was mediated via an apoptotic intrinsic pathway including mitochondrial damage and was caspase-dependent. These data also suggest that CAUE is a powerful anti-leukemic agent that acts via induction of apoptosis by mitochondrial damage and selective action in leukemia cells.


Biological & Pharmaceutical Bulletin | 2005

Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice.

Syu-ichi Kanno; Ayako Tomizawa; Takako Hiura; Yuu Osanai; Ai Shouji; Mayuko Ujibe; Takaharu Ohtake; Katsuhiko Kimura; Masaaki Ishikawa


Life Sciences | 2006

Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages

Syu-ichi Kanno; Ai Shouji; Ayako Tomizawa; Takako Hiura; Yuu Osanai; Mayuko Ujibe; Yutaro Obara; Norimichi Nakahata; Masaaki Ishikawa


Biological & Pharmaceutical Bulletin | 2008

Costunolide-induced apoptosis is caused by receptor-mediated pathway and inhibition of telomerase activity in NALM-6 cells.

Syu-ichi Kanno; Yasue Kitajima; Mai Kakuta; Yuu Osanai; Kaori Kurauchi; Mayuko Ujibe; Masaaki Ishikawa


Biological & Pharmaceutical Bulletin | 2006

Melatonin Protects on Toxicity by Acetaminophen But Not on Pharmacological Effects in Mice

Syu-ichi Kanno; Ayako Tomizawa; Takako Hiura; Yuu Osanai; Mai Kakuta; Yasue Kitajima; Kimiko Koiwai; Takaharu Ohtake; Mayuko Ujibe; Masaaki Ishikawa


Biological & Pharmaceutical Bulletin | 2007

Resistance to Ara-C Up-Regulates the Activation of NF-κB, Telomerase Activity and Fas Expression in NALM-6 Cells

Syu-ichi Kanno; Takako Hiura; Ai Shouji; Yuu Osanai; Mayuko Ujibe; Masaaki Ishikawa


Biological & Pharmaceutical Bulletin | 2007

Preventive effect of trimidox on oxidative stress in U937 cell line

Syu-ichi Kanno; Mai Kakuta; Yasue Kitajima; Yuu Osanai; Kaori Kurauchi; Takaharu Ohtake; Mayuko Ujibe; Kouji Uwai; Mitsuhiro Takeshita; Masaaki Ishikawa


Basic & Clinical Pharmacology & Toxicology | 2006

Trimidox induces apoptosis via cytochrome c release in NALM-6 human B cell leukaemia cells.

Syu-ichi Kanno; Kohji Uwai; Ayako Tomizawa; Takako Hiura; Yuu Osanai; Mayuko Ujibe; Mitsuhiro Takeshita; Takaharu Ohtake; Katsuhiko Kimura; Masaaki Ishikawa


Journal of Pharmacological Sciences | 2007

Inhibitory Effect of Trimidox on Lipopolysaccharide-Induced Nitric Oxide Production in RAW 264.7 Macrophages

Syu-ichi Kanno; Mai Kakuta; Yasue Kitajima; Yuu Osanai; Kaori Kurauchi; Takaharu Ohtake; Mayuko Ujibe; Kouji Uwai; Mituhiro Takeshita; Masaaki Ishikawa

Collaboration


Dive into the Yuu Osanai's collaboration.

Top Co-Authors

Avatar

Masaaki Ishikawa

Tohoku Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Syu-ichi Kanno

Tohoku Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Mayuko Ujibe

Tohoku Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Takaharu Ohtake

Tohoku Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Ayako Tomizawa

Tohoku Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Takako Hiura

Tohoku Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Kaori Kurauchi

Tohoku Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Mai Kakuta

Tohoku Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Yasue Kitajima

Tohoku Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Ai Shouji

Tohoku Pharmaceutical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge